Neurogenea

N/A

Report date: 2025/01/26 16:44:17

Base Information

Drug NameNeurogenea

Drug Alias Nameautologous bone marrow mononuclear cells + G-CSF therapy (Biogenea)

ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Hematopoietic stem cells therapyCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapy

Mechanisms of ActionNeuroprotectants

TargetsUpdating

Therapy Area/IndicationsAutistic DisorderSpinal Cord InjuriesAlzheimer Disease +[8]

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryGreece

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesBiogenea CellGenea

China Registration ClassN/A

Develop Information

Active CompaniesBiogenea CellGenea

Inactive CompaniesN/A

Active IndicationsAutistic DisorderSpinal Cord InjuriesAlzheimer Disease +[8]

Inactive IndicationsN/A

Other Information

ATC CodeN/A